Home CDMOs At The Core Of Next-Generation Pharma Models
 

Keywords :   


CDMOs At The Core Of Next-Generation Pharma Models

2016-05-02 10:34:21| drugdiscoveryonline Home Page

By William E. Weiser, Ph.D., Global Head, PDS Analytical Sciences In today’s pharmaceutical industry, the economic strains of keeping a company completely vertically integrated are no longer feasible. Smaller, virtual drug companies simply do not have the resources necessary to translate a molecule to a drug product, and larger companies can no longer endure the financial burden of keeping these resources in-house in the face of unpredictable pipelines. As these companies turn to outsourcing to bridge these gaps, they each bring a unique set of variables to the table that needs to be considered when forecasting manufacturing operations and supply chain management.

Tags: models core pharma nextgeneration

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
23.11contactglove tundratracker
23.11
23.11RUSSELUNO
23.11C282 800yd IP54
23.11X-FLY4 27.5
23.118
23.11 (1~40)
23.1101DVDBOX
More »